Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 28;16:359–371. doi: 10.2147/JIR.S387534

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 He et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Adjusted association between high-sensitivity C-reactive protein trajectories and following clinical outcomes.

Notes: Adjusted for age, sex, New York Heart Association class, history of hypertension, atrial fibrillation, coronary heart disease, valvular heart disease, anemia, hypoalbuminemia, diabetes, reduced renal function, COPD, stroke, pneumonia at admission, heart failure presentation (new-onset heart failure, decompensated chronic heart failure), left ventricular ejection fraction subtypes (heart failure with reduced ejection fraction, heart failure with mildly reduced ejection fraction, heart failure with preserved ejection fraction), 12-month N-terminal pro-B type natriuretic peptide levels, self-reported 12-month medication of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor neprilysin inhibitors, β-blockers, and aldosterone antagonists.

Abbreviation: CI, confidence interval.